Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Glaxosmithkline Pharmaceuticals informs about issuance of duplicate share certificate

11 Jul 2019

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company Karvy Fintech has received request for issue of duplicate Share Certificates from Santur Ganapathi Vaman Mallya. The Company shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s).

The above information is a part of company’s filings submitted to BSE.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1515.50 35.00 (2.36%) Jun 11, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 681.25
Dr. Reddys Lab 5451.20
Lupin 1230.25
Piramal Enterprises 2252.60
Cadila Healthcare 665.00
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback